ABvac40

· Araclon Biotech S.L.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABvac40, covering 2017-04-14 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD [Phase 2]